Influenza Hemagglutinin (HA) Peptide: High-Specificity Epitope Tag for Protein Detection and Purification

Executive Summary: The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic, nine-amino acid epitope tag derived from the human influenza hemagglutinin protein and is widely used in molecular biology for the detection and purification of HA-tagged proteins (APExBIO). The peptide exhibits high solubility (≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, ≥46.2 mg/mL in water) and is supplied with >98% purity confirmed by HPLC and mass spectrometry (olaparib.net). It functions by competitively binding anti-HA antibodies, enabling efficient elution of HA fusion proteins during immunoprecipitation assays (Dong et al., 2025). The HA tag is essential in protein-protein interaction studies and has demonstrated compatibility with a variety of buffers and workflows (dykddddk.com). For optimal performance, storage desiccated at -20℃ is required; long-term storage of solutions is not recommended.

Biological Rationale

The Influenza Hemagglutinin (HA) Peptide serves as a molecular tag for recombinant proteins, facilitating detection, purification, and downstream functional analysis. The HA tag sequence (YPYDVPDYA) corresponds to an immunodominant epitope from the influenza virus hemagglutinin protein, which is not commonly found in mammalian systems, thereby minimizing background noise in detection assays (Dong et al., 2025). This specificity makes the HA tag a preferred choice for protein-protein interaction and immunoprecipitation studies in both mammalian and non-mammalian cells (olaparib.net). The HA tag system is compatible with a wide range of anti-HA antibodies and magnetic bead-based capture reagents, enabling flexible assay designs.

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA tag peptide functions as a competitive inhibitor for anti-HA antibodies. When used in immunoprecipitation or affinity purification workflows, it displaces HA-tagged proteins from the antibody or bead complex by occupying the antibody's binding site (APExBIO). This enables gentle, non-denaturing elution of HA-tagged fusion proteins. The HA peptide's short, defined sequence confers high specificity and minimal cross-reactivity, ensuring that elution is both efficient and selective (GTP-binding-Protein-Fragment-G-Alpha.com). The peptide's high solubility in DMSO, ethanol, and water facilitates its use in diverse buffer conditions, allowing for optimized elution protocols according to experimental needs.

Evidence & Benchmarks

• HA peptide (YPYDVPDYA) enables competitive elution of HA-tagged proteins from anti-HA beads with >90% recovery under non-denaturing conditions (Dong et al., 2025).
• Purity of APExBIO A6004 HA peptide is >98%, validated by HPLC and mass spectrometry, ensuring batch-to-batch reproducibility (APExBIO).
• Solubility is quantified as ≥55.1 mg/mL in DMSO, ≥100.4 mg/mL in ethanol, and ≥46.2 mg/mL in water at room temperature, facilitating its use in concentration-dependent workflows (olaparib.net).
• HA tag is orthogonal to mammalian proteomes, minimizing non-specific binding in human, mouse, and rat cell lines (gdc-0449.com).
• Competitive elution using HA peptide preserves protein complex integrity for downstream mass spectrometry or functional assays (2xtaqpc.com).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is extensively used for:

• Affinity purification of HA-tagged recombinant proteins in cell lysates.
• Elution of protein complexes during immunoprecipitation assays using anti-HA antibodies or magnetic beads.
• Facilitating protein-protein interaction, ubiquitination, and post-translational modification studies (Dong et al., 2025).
• Enabling detection of HA-tagged proteins via western blotting, ELISA, or immunofluorescence using anti-HA antibodies.

This article expands on "Influenza Hemagglutinin (HA) Peptide: High-Purity HA Tag ..." by providing updated benchmarks and storage guidelines for the latest A6004 batches from APExBIO. For optimized protocols and troubleshooting, see "Optimizing Immunoprecipitation: Influenza Hemagglutinin (...", which focuses on workflow reproducibility; this article extends those insights with new solubility and purity metrics. For advanced mechanistic context in protein-protein interaction studies, "Influenza Hemagglutinin (HA) Peptide: Precision Tag for P..." is contrasted here by a focus on practical limits and batch validation.

Common Pitfalls or Misconceptions

• The HA peptide cannot elute proteins that are covalently crosslinked to beads or antibodies.
• Overuse of the peptide (>10 mM) may lead to non-specific interactions and reduced specificity.
• Long-term storage of peptide solutions leads to decreased activity; always store desiccated powder at -20℃.
• The HA tag does not function as a universal tag for all protein families; steric hindrance or protease sensitivity may affect performance.
• HA peptide-based elution requires compatible anti-HA antibodies; not all commercial clones are compatible with all experimental conditions.

Workflow Integration & Parameters

The APExBIO Influenza Hemagglutinin (HA) Peptide (SKU: A6004) integrates into standard immunoprecipitation and affinity purification protocols. Recommended working concentrations range from 0.5 mM to 5 mM, depending on the binding affinity of the anti-HA antibody used and the desired elution stringency. The peptide is soluble in water, DMSO, or ethanol, allowing flexibility in buffer composition. Buffer conditions should be optimized to preserve protein conformation and complex integrity. Elution is typically performed at 4℃ to minimize protein degradation. The peptide is stable as a lyophilized powder at -20℃, but reconstituted solutions should be prepared fresh for each experiment (APExBIO).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide is a cornerstone reagent for molecular biology, enabling the reliable and specific detection, purification, and functional study of HA-tagged proteins. Its high purity, solubility, and specificity support quantitative, reproducible research, including in complex models such as ubiquitination and metastasis pathways (Dong et al., 2025). Continued optimization of peptide-antibody systems, as exemplified by APExBIO's A6004 product, will further enhance the reproducibility and scalability of protein-protein interaction studies.